Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Bioprocess Automation Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The bioprocess automation market size has experienced rapid expansion in recent years. This market is projected to grow from $6.4 billion in 2025 to $7.21 billion in 2026, registering a compound annual growth rate (CAGR) of 12.6%. Historically, its growth can be attributed to the expansion of biopharmaceutical manufacturing, the increasing complexity of biologics production, the adoption of programmable control systems, the demand for consistent product quality, and the expansion of clinical manufacturing operations.
The bioprocess automation market is poised for rapid expansion over the next few years. It is projected to achieve a size of $11.52 billion by 2030, advancing at a compound annual growth rate (CAGR) of 12.4%. This anticipated growth is fueled by factors such as increased investments in continuous bioprocessing, a growing requirement for scalable automation platforms, the development of cell and gene therapy manufacturing, the integration of AI for process optimization, and the establishment of smart biomanufacturing facilities. Noteworthy trends during this forecast period include the increasing adoption of automated bioprocess control platforms, the rising incorporation of real-time process analytics, the expanding deployment of single-use bioprocessing automation, the proliferation of closed-loop process control systems, and a sharpened focus on data integrity and compliance.
Download A Free Sample Report For Comprehensive Market Insights:
Bioprocess Automation Market Demand Drivers: What Is Fueling Industry Growth?
The expanding availability of personalized medicines is anticipated to propel the growth of the bioprocess automation market in the future. This medical approach customizes healthcare decisions, practices, interventions, and treatments according to the unique characteristics of each patient. Bioprocess automation supports personalized medicine by enabling the precise and scalable production of patient-specific therapies. For instance, in February 2024, the Personalised Medicine Coalition, a US-based healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six approvals in 2022. Consequently, the increasing volume of personalized medicines is fueling the expansion of the bioprocess automation market.
Bioprocess Automation Market Segment Outlook: Which Categories Are Expanding The Fastest?
The bioprocess automation market covered in this report is segmented –
1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems
Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers
Bioprocess Automation Market Transformation Trends: Which Innovations Are Driving Change?
Major companies operating in the bioprocess automation market are actively developing innovative solutions, such as bioreactors, to simplify bioprocessing operations. A bioreactor is an engineered system or device providing an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that offers technologies and services to advance and accelerate the development and manufacture of therapeutics, launched X-platform bioreactors designed to simplify single-use upstream bioprocessing operations. This technology is easy to operate, flexible, and more efficient in its process. It was initially offered in 50 and 200 L capacities. These bioreactors can increase process efficiency through ergonomic improvements, enhanced production capability, and simplified supply chain operations. The X-platform bioreactors are suitable for manufacturing cell and gene therapies, viral vectors, and monoclonal antibodies (mAbs).
Bioprocess Automation Market Key Companies And Competitive Benchmarking
Major companies operating in the bioprocess automation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Parker-Hannifin Corporation, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf SE, Repligen Corporation, BIONET Engineering, Pierre Guerin Technologies, Bioengineering AG, Genedata AG, ILS Automation LLC, INFORS HT AG, Synthace Ltd., Automated Control Concepts Inc., BlueSens gas sensor GmbH, Securecell AG, Flownamics Analytical Instruments Inc., PendoTECH LLC, Sartorius Stedim Biotech S.A.
Access The Complete Bioprocess Automation Market Report:
Bioprocess Automation Market Geographic Distribution And Regional Opportunities
North America was the largest region in the bioprocess automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.